Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Drugs Made In America Acquisition Corp. (DMAA) since 2025 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Drugs Made In America Acquisition Corp.. Table 2 shows the detailed insider transactions. This company's CIK number is 2028614.
Total stock buying since 2025: $0.
Total stock sales since 2025: $0.
Total stock option exercises since 2025: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 800,000 | $0 | 11,396,726 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-01 | 800,000 | $0 | 11,396,726 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-29 | Drugs Made In America Acquisition Llc | Buy | 400,000 | .00 | 0 |
| 2025-01-29 | Drugs Made In America Acquisition Llc | Sale | 5,698,363 | .00 | 0 |
| 2025-01-29 | Stockwell Lynn (CEO and Executive COB) | Buy | 400,000 | .00 | 0 |
| 2025-01-29 | Stockwell Lynn (CEO and Executive COB) | Sale | 5,698,363 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of DMAA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Drugs Made In America Acquisition Corp. (symbol DMAA, CIK number 2028614) see the Securities and Exchange Commission (SEC) website.